TY  - GEN
ED  - European Monitoring Centre for Drugs and Drug Addiction
TI  - Annual Report 2009: The state of the drugs problem in Europe
T2  - TDAC09001ENC
SN  - 9789291683840
AV  - HV5840.E8 E97 2009
PY  - 2009///
CY  - Luxembourg
PB  - Office for Official Publications of the European Communities
KW  - Drug abuse
KW  - Europe
KW  - İlaç kötüye kullanımı
KW  - Avrupa
N1  - Kaynakça var; Introductory note 9 -- Commentary: Hitting a moving target —- the challenge of developing a pragmatic policy response to a changing -- drug problem 11 -- Chapter 1: Policies and laws -- International and EU policy developments -- National strategies -- Public expenditure " National legislation -- Research 18 -- Chapter 2: Responding to drug problems in Europe — an overview -- Prevention -- Treatment -- Horm reduction -- Social reintegration -- Drug low enforcement ond offences -- Healtfi and social responses in prison 26 -- Chapter 3: Cannabis -- Supply and availability -- Prevalence and patterns of use -- Treatment 38 -- Chapter 4: Amphetamines, ecstasy and hallucinogenic substances -- Supply and availability -- Prevalence andpatterns of use -- Recreational settings -- Treatment 49 -- Chapter 5: Cocaine and crack cocaine -- Supply and availability -- Prevalence and patterns of use -- Health consequences -- Problem use and treatment demand -- Treatment and horm reduction 60 -- Chapter 6: Opioid use and drug injection -- Supply and availability -- Problem opioid use -- Injecting drug use -- Treatment 71 -- Chapter 7: Drug-related infectious diseases and drug-related deaths -- Infectious diseases -- Responding to Infectious diseases -- Deaths and mortality -- Reducing deaths 80 -- Chapter 8: New drugs and emerging trends -- EU action on new drugs --'Spice' and related synthetic connabinoids -- Internet shops -- Follow-up on substances 91
N2  - Summary: The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policymakers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures
ER  -